INDO US BIOTECH LTD Share Price

₹ 67.91

+₹1.60 (2.41%)
1D
Last updated 04 Nov, 2026, 13:01 IST
NSE: INDOUS
|
Agriculture

INDO US BIOTECH LTD Share Price Today

As of 4 Nov 2026, INDO US BIOTECH LTD share price is ₹67.91. The stock opened at ₹66.31, compared to its previous close of ₹66.31. During today's trading session, INDO US BIOTECH LTD share price moved in the range of ₹66.00 to ₹68.92, with an average price of ₹67.46 for the day. Looking at its last 52-week, the stock has touched a low of ₹57.50 and a high of ₹159.00. On the performance front, INDO US BIOTECH LTD share price has declined by 36.41% over the last six months and is down 51.20% on a year-on-year basis.

Share price over the last 1 day rose from 66.31 to 67.91, ranging between 66.00 and 68.92.
₹66.00
2.41% up today
₹68.92
1D LOW
1D HIGH

INDO US BIOTECH LTD Stock Insights

Stock Performance
UnderperformingUnderperforming Nifty by 41.43 % in last 1 yr
INDO US BIOTECH LTD stock performance
Open₹66.31
High₹68.92
Low₹66.00
Prev. close₹66.31
INDO US BIOTECH LTD trading activity
Volume1,368
Average traded price₹67.62
Last traded time01:01:25 04 Nov
Last traded quantity10
Circuit
L
H
₹53.05
₹79.57
52-week
L
H
₹57.50
₹159.00
Mkt Cap Cr
138.82
P/E
12.23
P/B
1.61
ROA
9.65%
ROE
16.91%
ROCE
15.11%
Quick Ratio
1.91
EV/EBITDA
10.71

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Indo US Bio-Tech has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Indo US Bio-Tech appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Indo US Bio-Tech earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Hindustan Unilever4,45,517.7530.799.518.18%22.93%27.44%0.9221.74
ITC3,33,348.8716.514.620.95%28.53%37.26%1.9211.62
Nestle India2,29,855.0756.3639.7928.76%70.58%87.52%0.4235.78
Varun Beverages1,33,997.5352.658.5912.13%15.51%19.85%1.2130.02
Lenskart1,15,707.34174.7713.364.64%5.65%7.0%1.8553.58
Britannia Industries1,11,954.3845.3623.1926.82%49.61%51.85%0.829.43
Marico1,03,743.2849.9321.9115.77%41.85%40.56%1.0438.72
Tata Consumer Products1,01,444.1059.454.595.36%7.69%9.84%1.0331.91
Godrej Consumer Products83,657.7942.936.738.86%15.67%17.34%0.726.33
Dabur India66,239.5634.045.811.14%16.59%20.18%1.2520.91

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

INDO US BIOTECH LTD Company Background

ISIN
INE250Z01010
Sector Market Cap
₹ 138.82 Cr

Indo US Bio-Tech Limited is a specialized agriculture seed company with its own research station, marketing network and seed production bases. The Company operates through the Seed Cultivation, processing and trading segment. It is involved in crop research and development through breeding, production of seeds, processing, packing and marketing of hybrid and open-pollinated varieties of agricultural crops. Its product portfolio includes a diversified variety of agriculture seeds namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, cumin, coriander, and others. It has a distribution network in the states of Gujarat, Maharashtra, Madhya Pradesh, Chhattisgarh, Rajasthan, Punjab and others. It also exports to many countries, namely the United States, New Jersey, Palestine, Cameroon, Kuwait and others.

INDO US BIOTECH LTD Financial Highlights

  • Revenue: INDO US BIOTECH LTD reported revenue of ₹50.24 crore in FY22 vs ₹40.15 crore in FY21. It showed an increase of 25.13% on a yearly basis.
  • Operating Profit: INDO US BIOTECH LTD reported an operating profit of ₹5.31 crore in FY22 vs ₹3.93 crore in FY21. It showed an increase of 35.11% on a year-on-year basis.
  • Net Profit: INDO US BIOTECH LTD reported a net profit of ₹5.06 crore in FY22 vs ₹4.90 crore in FY21. It showed an increase of 3.27% on a yearly basis.

INDO US BIOTECH LTD Quarterly Result Highlights

  • INDO US BIOTECH LTD reported revenue of ₹15.10 crore in Sep 2026, compared with ₹33.11 crore in Jun 2026, representing a decrease of 54.39% on a quarter-on-quarter (QoQ) basis.
  • INDO US BIOTECH LTD reported an operating loss of ₹3.65 crore in Sep 2026, compared with ₹3.08 crore in Jun 2026, representing a decrease of 218.51% on a quarter-on-quarter (QoQ) basis.
  • INDO US BIOTECH LTD reported a loss of ₹3.67 crore in Sep 2026, compared with ₹3.04 crore in Jun 2026, reflecting a decrease of 220.72% on a QoQ basis.
  • The earnings per share (EPS) of INDO US BIOTECH LTD stood at ₹8.12 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
68.29%
FII
0.01%
Other DII
0.25%
Retail and other
31.45%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.18%
Jun 20260.01%
Sep 20260.01%

INDO US BIOTECH LTD Investment Returns

1 day
-2.41%
1 week
-8.37%
1 month
-13.60%
1 year
-51.20%
3 years
-77.34%
5 years
-77.34%

INDO US BIOTECH LTD Share Price History

INDO US BIOTECH LTD share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
03 Nov 26
₹68.20 / ₹66.31
-2.41%
02 Nov 26
₹68.00 / ₹67.95
-7.60%
30 Oct 26
₹79.79 / ₹73.54
-6.15%
29 Oct 26
₹84.00 / ₹78.36
-9.77%
Show more

INDO US BIOTECH LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2022Mar 2021Mar 2020
Revenue₹50.06₹40.11₹39.76
Other Income₹0.18₹0.04₹0.01
Total Revenue₹50.24₹40.15₹39.77
Total Expenses₹44.93₹36.22₹36.90
Profit Before Tax₹5.31₹3.93₹2.86
Tax₹0.25-₹0.97₹0.33
Profit After Tax₹5.06₹4.90₹2.53
EPS - Basic₹8.27₹8.07₹4.18
EPS - Diluted₹8.27₹8.07₹4.18

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2022Mar 2021Mar 2020
Profit before tax₹5.31₹3.93₹2.86
Income before WC changes₹6.95₹5.36₹3.96
Change in Assets-₹6.85-₹6.76-₹10.38
Change in Liabilities₹2.99₹1.70₹5.61
Change in WC-₹3.86-₹5.06-₹4.77
Cash flow from Operations₹2.70₹0.16-₹0.84
Cash flow from Investing-₹5.44-₹1.78-₹0.57
Cash flow from Financing₹2.65₹1.55₹1.53
Total Cash Flow-₹0.09-₹0.07₹0.12
Cash (Start of the year)₹0.13₹0.20₹0.08
Cash (End of the year)₹0.05₹0.13₹0.20

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2022Mar 2021Mar 2020
Non-Current Assets₹8.78₹5.57₹2.80
Current Assets₹46.84₹38.13₹31.90
Total Assets₹55.62₹43.71₹34.70
Current Liabilities₹12.28₹18.09₹16.73
Net Current Asset₹34.55₹20.04₹15.17
Non-Current Liabilities₹4.82₹4.27₹1.52
Equity Capital₹38.51₹21.34₹16.44
Total Equity & Liabilities₹55.62₹43.71₹34.70

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹103.84₹72.84₹61.74₹50.05
Other Income₹0.18₹0.32₹0.02₹0.18
Total Revenue₹104.02₹73.15₹61.77₹50.24
Total Expenses₹87.49₹64.36₹54.38₹44.75
Profit Before Tax₹16.53₹8.79₹7.39₹5.49
Tax₹0.26₹0.55₹0.15₹0.25
Profit After Tax₹16.27₹8.24₹7.24₹5.24
EPS - Basic₹8.12₹4.11₹7.51₹8.56
EPS - Diluted₹8.12₹4.11₹7.51₹8.56

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹16.53₹8.79₹7.39₹5.49
Income before WC changes₹19.53₹11.05₹9.40₹7.11
Change in Assets-₹14.90-₹12.28-₹7.73-₹6.86
Change in Liabilities-₹2.85₹3.76-₹0.83₹3.05
Change in WC-₹17.76-₹8.52-₹8.56-₹3.81
Cash flow from Operations₹1.42₹2.22₹0.53₹2.91
Cash flow from Investing-₹0.79-₹2.53-₹6.67-₹5.40
Cash flow from Financing-₹1.48₹1.22₹6.29₹2.41
Total Cash Flow-₹0.85₹0.91₹0.14-₹0.08
Cash (Start of the year)₹1.10₹0.19₹0.05₹0.13
Cash (End of the year)₹0.25₹1.10₹0.19₹0.05

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹11.12₹11.36₹9.56₹8.52
Current Assets₹86.73₹73.09₹59.91₹47.06
Total Assets₹97.84₹84.46₹69.47₹55.57
Current Liabilities₹16.34₹18.86₹12.29₹12.21
Net Current Asset₹70.39₹54.23₹47.62₹34.85
Non-Current Liabilities₹2.99₹2.85₹2.68₹4.49
Equity Capital₹78.52₹62.75₹54.50₹38.88
Total Equity & Liabilities₹97.84₹84.46₹69.47₹55.57
* All values are in INR Crore
INDO US BIOTECH LTD market depth
Bid quantityBid priceAsk priceAsk quantity
27667.9167.99126
1067.026842
1567.0168.1510
1026768.496
666.968.557
Total bid quantity409
Total ask quantity241
INDO US BIOTECH LTD technical summary
Bearish indicators2
Neutral indicators6
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
42.7
Neutral
ATR (14)
7.5
Neutral
STOCH(9,6)
30.03
Neutral
STOCH RSI (14)
52.15
Neutral
ADX(9)
25.84
Bearish
UO(9)
46.21
Neutral
ROC(12)
-7.44
Bearish
WillR(14)
-69.97
Neutral
Period
Simple value
Exponential vaue
5D
74.6
70.45
10D
70.43
71.24
20D
71.63
72.24
50D
76.08
75.85
100D
81.2
82.91
Volume trend — traded volume by day
4 Nov0L
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct1L
28 Oct3L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

INDO US BIOTECH LTD
Agriculture
Add Stock
Add Another

INDO US BIOTECH LTD Returns Calculator

Top Gainers

GMDCLTD Share Price
₹465.25
+39.65 (+9.32%)
SAREGAMA Share Price
₹613.90
+51.7 (+9.2%)
EQUITASBNK Share Price
₹56.94
+4.29 (+8.15%)
LINDEINDIA Share Price
₹6272.00
+423.5 (+7.24%)
UNOMINDA Share Price
₹1200.20
+75.7 (+6.73%)
See more

Top Losers

SKFINDIA Share Price
₹1392.30
-79.6 (-5.41%)
AIAENG Share Price
₹3226.60
-163.1 (-4.81%)
ALKYLAMINE Share Price
₹1586.60
-72.2 (-4.35%)
ZYDUSLIFE Share Price
₹1195.60
-45 (-3.63%)
BATAINDIA Share Price
₹627.95
-21.85 (-3.36%)
See more

INDO US BIOTECH LTD Share Price FAQs

Please be aware that INDO US BIOTECH LTD stock prices are subject to continuous fluctuations due to various factors.